Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan
· Delayed Price · Currency is TWD 106.00
-3.00 (-2.75%)
At close: Dec 5, 2025
Handa Pharmaceuticals Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,677 | 10,576 | 25,891 | 16,074 | 8,451 | 2,820 | Upgrade
|
| Market Cap Growth | 95.22% | -59.15% | 61.07% | 90.20% | 199.72% | -18.91% | Upgrade
|
| Enterprise Value | 14,112 | 8,085 | 23,747 | 15,869 | 8,249 | 2,326 | Upgrade
|
| Last Close Price | 106.00 | 73.58 | 179.00 | 118.61 | 65.86 | 23.12 | Upgrade
|
| PE Ratio | 23.39 | 22.37 | 35.62 | - | - | - | Upgrade
|
| PS Ratio | 10.31 | 12.73 | 23.40 | 81.32 | 289.08 | 97.71 | Upgrade
|
| PB Ratio | 3.71 | 3.39 | 9.39 | 22.29 | 18.25 | 5.23 | Upgrade
|
| P/TBV Ratio | 4.49 | 4.89 | 9.52 | 23.46 | 19.80 | 5.59 | Upgrade
|
| P/FCF Ratio | 94.95 | 21.59 | 38.79 | - | - | - | Upgrade
|
| P/OCF Ratio | 85.85 | 21.25 | 38.74 | - | - | - | Upgrade
|
| EV/Sales Ratio | 8.72 | 9.73 | 21.47 | 80.28 | 282.15 | 80.61 | Upgrade
|
| EV/EBITDA Ratio | 14.21 | 19.20 | 34.00 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 16.27 | 19.34 | 34.25 | - | - | - | Upgrade
|
| EV/FCF Ratio | 80.34 | 16.51 | 35.58 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.09 | 0.02 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.28 | 0.08 | 0.02 | - | - | - | Upgrade
|
| Asset Turnover | - | 0.26 | 0.58 | 0.31 | 0.05 | 0.04 | Upgrade
|
| Quick Ratio | 32.25 | 8.49 | 12.89 | 11.63 | 10.05 | 9.05 | Upgrade
|
| Current Ratio | 32.44 | 8.72 | 12.96 | 13.07 | 10.57 | 10.79 | Upgrade
|
| Return on Equity (ROE) | - | 16.10% | 41.81% | -6.76% | -49.43% | -41.47% | Upgrade
|
| Return on Assets (ROA) | - | 8.07% | 22.64% | -8.54% | -29.36% | -27.20% | Upgrade
|
| Return on Capital (ROIC) | - | 8.82% | 24.62% | -8.99% | -30.89% | -28.46% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.80% | 13.10% | 24.50% | -11.80% | -54.20% | -58.30% | Upgrade
|
| Earnings Yield | 4.10% | 4.47% | 2.81% | -0.25% | -2.93% | -10.00% | Upgrade
|
| FCF Yield | 1.05% | 4.63% | 2.58% | -1.32% | -2.19% | -11.20% | Upgrade
|
| Dividend Yield | 1.42% | 2.04% | 0.56% | - | - | - | Upgrade
|
| Payout Ratio | 33.25% | 29.84% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -6.72% | -4.73% | -7.29% | -6.65% | -1.87% | -5.35% | Upgrade
|
| Total Shareholder Return | -5.34% | -2.69% | -6.73% | -6.65% | -1.87% | -5.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.